Insiders · TXMD

TXMD insider transactions

TherapeuticsMD Inc. (TXMD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TXMD insiders

Everyone who has filed a Form 3, 4, 5 or 144 at TherapeuticsMD Inc., latest first. Follow anyone to get their next filing.

• Tommy G ThompsonDirector+$14.4K
• Gail K NaughtonDirector-$20.6K
• Cooper C. CollinsDirector+$1.31M
• Marlan D WalkerChief Executive Officer+$2,483-$78.1K
• Rubric Capital Management LPDirector, 10% owner, since July 2022+$29.7M
• Joseph ZieglerOfficer, since August 2023
• Michael C DoneganOfficer-$40.9K
• Brian BernickOfficer, since September 2022-$6,621
• Mark A GlickmanOfficer, since October 2021-$2,165
• Angus C. RussellDirector
• Paul BisaroDirector+$39.5K
• Jules A. MusingDirector
• Karen LingDirector
• Justin Hunter RobertsDirector, since August 2022
• Hugh O'DowdOfficer
• James DAreccaOfficer-$81.2K
• J Martin CarrollDirector
• Robert G FinizioOfficer, Director-$70.4K
• Edward BorkowskiOfficer-$46K
• John C.K. Milligan IVOfficer-$46K

Recent Form 3, 4, and 5 filings for TXMD

• 315d
  Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 369d
  SEC Form 4 filed by Director Thompson Tommy G

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 369d
  SEC Form 4 filed by Director Naughton Gail K

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 369d
  SEC Form 4 filed by Director Collins Cooper C.

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 369d
  SEC Form 4 filed by Chief Executive Officer Walker Marlan D

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 574d
  Director Thompson Tommy G bought $326 worth of shares (325 units at $1.00), increasing direct ownership by 2% to 14,779 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 574d
  Chief Executive Officer Walker Marlan D bought $489 worth of shares (490 units at $1.00), increasing direct ownership by 0.67% to 73,639 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 578d
  Chief Executive Officer Walker Marlan D bought $1,994 worth of shares (2,303 units at $0.87), increasing direct ownership by 3% to 73,149 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 627d
  Director Collins Cooper C. converted options into 8,500 shares, increasing direct ownership by 16% to 60,516 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 627d
  Director Naughton Gail K converted options into 8,500 shares (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 627d
  Director Thompson Tommy G converted options into 8,500 shares, increasing direct ownership by 143% to 14,454 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 627d
  Chief Executive Officer Walker Marlan D converted options into 8,281 shares, increasing direct ownership by 13% to 70,846 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 805d
  Director Collins Cooper C. bought $7,099 worth of shares (4,094 units at $1.73), increasing direct ownership by 9% to 52,016 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 808d
  Director Collins Cooper C. bought $2,039 worth of shares (1,200 units at $1.70), increasing direct ownership by 3% to 47,922 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1068d
  Walker Marlan D converted options into 70,000 shares and sold $43,684 worth of shares (19,050 units at $2.29), increasing direct ownership by 439% to 62,565 units (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1089d
  Rubric Capital Management Lp was granted 877,192 shares (SEC Form 4)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1176d
  SEC Form 4: Ziegler Joseph was granted 7,500 shares

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1176d
  SEC Form 3 filed by new insider Ziegler Joseph

  3 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1209d
  SEC Form 4 filed by Thompson Tommy G

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1209d
  SEC Form 4 filed by Naughton Gail K

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1209d
  SEC Form 4 filed by Collins Cooper C.

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1229d
  SEC Form 4 filed by Rubric Capital Management Lp

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1285d
  SEC Form 4 filed by Walker Marlan D (Amendment)

  4/A - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1305d
  SEC Form 4 filed by Walker Marlan D

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1305d
  SEC Form 4 filed by Donegan Michael C

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1355d
  SEC Form 4 filed by Walker Marlan D

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1355d
  SEC Form 4 filed by Donegan Michael C

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1356d
  SEC Form 4: Rubric Capital Management Lp returned $38,657,000 worth of Series A Preferred Stock to the company (29,000 units at $1,333.00) (Amendment)

  4/A - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1365d
  SEC Form 5: Walker Marlan D gifted 716 shares, decreasing direct ownership by 11% to 5,969 units

  5 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1379d
  SEC Form 4: Donegan Michael C converted options into 5,940 shares and sold $8,621 worth of shares (1,697 units at $5.08), increasing direct ownership by 56% to 11,853 units to cover taxes

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1384d
  SEC Form 4: Donegan Michael C converted options into 4,365 shares and sold $6,988 worth of shares (1,309 units at $5.34), increasing direct ownership by 67% to 7,610 units (for tax liability)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1406d
  SEC Form 4: Rubric Capital Management Lp sold $38,657,000 worth of Series A Preferred Stock (29,000 units at $1,333.00)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1429d
  SEC Form 4: Rubric Capital Management Lp bought $90,284 worth of shares (14,825 units at $6.09)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1431d
  SEC Form 4: Bernick Brian converted options into 3,167 shares and sold $6,621 worth of shares (1,255 units at $5.28), increasing direct ownership by 98% to 3,872 units to satisfy withholding tax

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1431d
  SEC Form 4: Walker Marlan D converted options into 2,554 shares and sold $5,185 worth of shares (1,048 units at $4.95), increasing direct ownership by 29% to 6,685 units to satisfy withholding tax

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1431d
  SEC Form 4: Glickman Mark A sold $2,165 worth of shares (440 units at $4.92) and converted options into 1,734 shares to cover withholding tax

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1431d
  SEC Form 4: Donegan Michael C converted options into 3,476 shares and sold $4,345 worth of shares (910 units at $4.78), increasing direct ownership by 129% to 4,554 units to satisfy withholding obligation

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1432d
  SEC Form 4: Rubric Capital Management Lp bought $115,639 worth of shares (20,413 units at $5.66)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1432d
  SEC Form 4: Naughton Gail K sold $20,635 worth of shares (3,922 units at $5.26), closing all direct ownership in the company

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1471d
  SEC Form 4: Rubric Capital Management Lp bought $7,000,000 worth of Series A Preferred Stock (7,000 units at $1,000.00)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Russell Angus C.

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Bisaro Paul

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Collins Cooper C.

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Thompson Tommy G

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Musing Jules A.

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Naughton Gail K

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4 filed by Ling Karen

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1498d
  SEC Form 4: Rubric Capital Management Lp bought $7,000,000 worth of Series A Preferred Stock (7,000 units at $1,000.00)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1515d
  SEC Form 3: New insider Bernick Brian claimed ownership of 37,167 shares

  3 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1531d
  SEC Form 3 filed by new insider Roberts Justin Hunter

  3 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Ling Karen converted options into 1,984 shares, increasing direct ownership by 76% to 4,591 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Naughton Gail K converted options into 1,984 shares, increasing direct ownership by 102% to 3,922 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Russell Angus C. converted options into 1,984 shares, increasing direct ownership by 52% to 5,792 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Thompson Tommy G converted options into 2,976 shares, increasing direct ownership by 100% to 5,954 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Bisaro Paul converted options into 1,984 shares, increasing direct ownership by 50% to 5,922 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Musing Jules A. converted options into 1,984 shares, increasing direct ownership by 97% to 4,022 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1541d
  SEC Form 4: Collins Cooper C. converted options into 1,984 shares, increasing direct ownership by 4% to 46,722 units

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1561d
  SEC Form 4: Rubric Capital Management Lp bought $2,666,800 worth of shares (565,000 units at $4.72) and bought $12,333,150 worth of Series A Preferred Stock (15,000 units at $822.21)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1575d
  SEC Form 4: Rubric Capital Management Lp bought $467,458 worth of shares (82,580 units at $5.66)

  4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
• 1575d
  SEC Form 3: New insider Rubric Capital Management Lp claimed ownership of 1,074,373 shares

  3 - TherapeuticsMD, Inc. (0000025743) (Issuer)